Chronic respiratory conditions affect almost one-third (31%) of Australians.

At JB Medical, we recognise the importance of respiratory support equipment and its vital role in preventing serious health problems such as heart disease and stroke as well as safeguarding the health of patients.


Respiratory solutions help to reduce risk.

We strive to protect the safety of patients and to provide relevant information to staff quickly with our solutions, which are suitable for hospitals, aged care institutions, and private homes.

Nursing staff and caregivers are kept informed of patient movement using Proximate Nurse Call’s motion detection technology. Various pressure-relieving gadgets, beds, and chairs can be fitted with them.

Providing a safe and supportive environment for the patient while they sleep, our roll-out beds help define sleeping arrangements.

By empowering nurses, we set the standard for early detection and prevent falls and injuries.

Mattresses that are low to the ground can mean the difference between a minor trauma and serious injury. Patients may be able to get on and off their beds with assistance from our beds.

The training and guidance that we provide on appropriately using our goods will benefit patients as well as extend the life of the equipment.


Our Respiratory solutions.


Leading the charge in the field of mobility aid education.

We at JB Medical are committed to providing our clients with the best possible use of our equipment. By providing instructions on how to use our products correctly, not only will patients benefit from better outcomes, but also the equipment’s lifespan will be extended.


Respiratory conditions

Obstructive sleep apnoea

Obstructive sleep apnoea (OSA) is a condition that causes interruptions in breathing due to multiple brief and temporary collapses or blockages of throat or airways, usually hundreds of times, during one sleep cycle (AIHW 2021). This is more prevalent in older age and in males (AIHW 2021).

OSA is the most common type of sleep-related breathing disorders in the global general population (AIHW 2021) where this can affect sleep quality and health. The symptoms and quality of life could be improved with effective diagnosis and successful treatments.

Eligible Australians can access Medicare-funded sleep study services for sleep disorder (including OSA) diagnosis. It costed the Australian government $47 million for sleep disorder diagnostic and $10 million for treatments in 2019 (AIHW 2021). The total Australian economic burden due to OSA is $541 million, which is 57% of the total healthcare cost of sleep disorders in 2019-20 (AIHW 2021).

Risk factors

Risk factors for OSA are mostly modifiable such as age, overweight/obesity, smoking, high alcohol consumption, physical inactivity, narrowed airway, type 2 diabetes, hypertension, sedative use and trauma (AIHW 2021).

Effects of OSA

OSA is known to have detrimental effects on sleep quality and health. Prolonged OSA could lead to cardiovascular disease and subsequent mortality (AIHW 2021). OSA patients also have increased risk of motor vehicle and occupational accidents, and this risk is easily reduced when OSA is effectively managed and treated with CPAP therapy (AIHW 2021).

Mortality rates after OSA

Unfortunately, if left untreated, OSA could have significant mortality rates among Australians. OSA related death (either underlying or associated cause) in 2018 was 0.8% of all deaths (or 1111; 67% males and 33% females).

Managing OSA

OSA is first and foremost managed by behavioural changes such as weight loss, smoking cessation, blood pressure and glucose checked together with the use of a CPAP machine. CPAP helps to achieve positive airway pressure ventilation by applying mild air pressure continuously. This helps to keep the airways open and unobstructed throughout the sleep, when the individual, whom otherwise, would not be able to achieve this on his/her own.

Frequently asked questions.